Showing results (11-20 of 33) with videos related to

Sort By:
Pageof 4
Frontiers in Endocrinology|September 14, 2020
Body Mass Index and Prognosis of COVID-19 Infection. A Systematic ReviewKarina Colombera Peres, Rachel Riera, Ana Luiza Cabrera Martimbianco, et al.
Clinics (Sao Paulo, Brazil)|June 6, 2012
Foxp3 expression is associated with aggressiveness in differentiated thyroid carcinomasLucas Leite Cunha, Elaine Cristina Morari, Suely Nonogaki, et al.
Chinese Clinical Oncology|June 11, 2024
Immunotherapy for patients with thyroid cancer: a comprehensive appraisalAlfredo Pinheiro Neto, Henrique Luca Lucchesi, Victor Alexandre Dos Santos Valsecchi, et al.
Cancer Cell International|July 21, 2021
The immune landscape of the microenvironment of thyroid cancer is closely related to differentiation statusLucas Leite Cunha, Guilherme Augusto Barcelos Domingues, Elaine Cristina Morari, et al.
Cancer Epidemiology|June 2, 2026
Trends and burden of oncologic emergencies in Brazil: A nationwide time series analysis (2008-2024)Guilherme Falcão Machado, Cassiano Pereira de Barros, Sai-Ching Jim Yeung, et al.
Endocrine Research|January 28, 2014
Both gender and concurrent chronic lymphocytic thyroiditis may influence the nuclear texture of papillary thyroid carcinomas cellsLucas Leite Cunha, Rita de Cássia Ferreira, Patricia Sabino de Matos, et al.
Clinics (Sao Paulo, Brazil)|August 31, 2011
Interleukin-10 but not interleukin-18 may be associated with the immune response against well-differentiated thyroid cancerLucas Leite Cunha, Alfio Jose Tincani, Ligia Vera Montalli da Assumpção, et al.
Clinical Endocrinology|August 19, 2014
CD8+ tumour-infiltrating lymphocytes and COX2 expression may predict relapse in differentiated thyroid cancerLucas Leite Cunha, Marjory Alana Marcello, Suely Nonogaki, et al.
Cancer Immunology, Immunotherapy : CII|November 19, 2016
Interleukin 10 expression is related to aggressiveness and poor prognosis of patients with thyroid cancerLucas Leite Cunha, Elaine Cristina Morari, Sueli Nonogaki, et al.
BMC Cancer|January 8, 2020
Expression of the NEK family in normal and cancer tissue: an immunohistochemical studyTalita Diniz Melo-Hanchuk, Mariana Bonjiorno Martins, Lucas Leite Cunha, et al.
Pageof 4